LISA MENGWASSER: Open Payments
NPI 1659724946 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 79 payments from 27 companies in 2025. Trend: 2023 $3,365 · 2024 $3,609 · 2025 $1,766
Food & beverage: $1,766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $246 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $218 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $156 |
| Lilly USA, LLC | 6 | $139 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Novo Nordisk Inc | 3 | $95 |
| PFIZER INC. | 4 | $88 |
| Aimmune Therapeutics, Inc. | 2 | $82 |
| Alexion Pharmaceuticals, Inc. | 1 | $79 |
| Teva Pharmaceuticals USA, Inc. | 1 | $73 |
Products named: CAPLYTA, XIFAXAN, MOUNJARO, Auvelity, VRAYLAR, REXULTI, ELIQUIS, ZENPEP.
Industry payments across MO — which companies pay providers there.
